Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations-Reference-Cited by-同舟云学术

Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations

Published:2022-03-02 Issue:3 Volume:5 Page:e220868
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Botton Jérémie¹,Semenzato Laura¹,Jabagi Marie-Joëlle¹,Baricault Bérangère¹,Weill Alain¹,Dray-Spira Rosemary¹,Zureik Mahmoud¹

Affiliation:

1. EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, Saint-Denis, France

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2789572/botton_2022_ld_220017_1645625927.16143.pdf

Reference6 articles.

1. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19.;Sadoff;N Engl J Med,2021

2. Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings.;Thompson;N Engl J Med,2021

3. Analysis of the effectiveness of the Ad26.COV2.S adenoviral vector vaccine for preventing COVID-19.;Corchado-Garcia;JAMA Netw Open,2021

4. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.;Tartof;Lancet,2021

5. Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people.;Semenzato;Lancet Reg Health Eur,2021

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress on drugs discovery study for treatment of COVID-19: repurposing existing drugs and current natural bioactive molecules;Applied Biological Chemistry;2023-12-13

2. Pharmacoepidemiology and public decision;Therapies;2023-09

3. Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines;Therapies;2023-09

4. Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!;Therapies;2023-09

5. Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?;Therapies;2023-09